New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Ayvakit avapritinib Click here for more information |
Blueprint Medicines | A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST). |
|
Palforzia peanut (Arachis hypogaea) allergen powder-dnfp |
Aimmune Therapeutics | An oral immunotherapy for patients with peanut allergy. |
|
Tazverik tazemetostat Click here for more information |
Epizyme | A methyltransferase inhibitor for advanced epithelioid sarcoma. |
|
Tepezza teprotumumab-trbw Click here for more information |
Horizon | A monoclonal antibody for thyroid eye disease. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Bynfezia Pen octreotide Click here for more information |
Sun Pharm. | New subcutaneous pen formulation for patients with acromegaly, carcinoid tumors, or vasoactive intestinal peptide tumors. |
|
Monoferric ferric derisomaltose Click here for more information |
Pharmacosmos | An intravenous iron replacement formulation for iron deficiency anemia. |
|
Trijardy XR empagliflozin/linagliptin/metformin Click here for more information |
Boehringer Ingelheim | New combination formulation for glycemic control in patients with type 2 diabetes. |
|
Valtoco diazepam nasal spray Click here for more information |
Neurelis | New nasal spray formulation for acute treatment of seizure clusters and acute repetitive seizures. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Belviq, Belviq XR lorcaserin Click here for more information |
Eisai | Voluntary withdrawal from the market due to concerns about an increased occurrence of cancer seen in a clinical trial. |